Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
British Journal of Clinical Pharmacology|June 20, 2020
Model informed dosing of hydroxycholoroquine in COVID-19 patients: Learnings from the recent experience, remaining uncertainties and gapsPauline Thémans, Nicolas Dauby, Loïc Schrooyen, et al.
The European Respiratory Journal|February 20, 2025
Incident tuberculosis in people with HIV across Europe from 2012-2022: incidence rates, risk factors, and regional differences in a multicentre cohort studyChristian Kraef, Ashley Roen, Daria Podlekareva, et al.
The European Respiratory Journal|March 12, 2016
Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBSimon Tiberi, Marie-Christine Payen, Giovanni Sotgiu, et al.
The European Respiratory Journal|April 15, 2016
Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBSimon Tiberi, Giovanni Sotgiu, Lia D'Ambrosio, et al.
The European Respiratory Journal|May 23, 2017
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre studySergey E Borisov, Keertan Dheda, Martin Enwerem, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 7, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility studyOnno Akkerman, Alena Aleksa, Jan-Willem Alffenaar, et al.
The European Respiratory Journal|October 12, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global reportSergey Borisov, Edvardas Danila, Andrei Maryandyshev, et al.
Pageof 2